The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Share News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.125
Bid: 17.75
Ask: 18.50
Change: 0.00 (0.00%)
Spread: 0.75 (4.225%)
Open: 18.125
High: 18.125
Low: 18.125
Prev. Close: 18.125
OPTI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

OptiBiotix Health signs North America manufacturing deal with Agropur

Mon, 24th Jun 2019 07:43

(Sharecast News) - OptiBiotix Health has entered into a manufacturing, supply and distribution agreement with Agropur, it announced on Monday.The AIM-traded firm said the agreement granted Agropur an exclusive license to manufacture, supply and distribute OptiBiotix's 'SlimBiome' weight management technology in the United States, Canada and Mexico.It described Agropur, founded in 1938, as a North American "dairy industry leader" with 8,800 employees and sales of $6.7bn in 2018.It processed more than 6.2 billion litres of milk per year at its 39 plants across North America, and boasted a portfolio of brands and products including Natrel, OKA, Iögo, BiPRO, Agropur Grand Cheddar, Olympic, Farmers, Island Farms, Québon, ISO Chill and Crino.SlimBiome, meanwhile, was OptiBiotix's flagship weight management product, which would be supplied by Agropur's Customs Solutions Group as a specialised functional ingredient.It could be incorporated into a wide range of applications, including human nutrition comprising of food and beverages, dairy, dietary supplements and sports nutrition, with the exception of extruded product in cereal particulates which is a market segment serviced by Cereal Ingredients.OptiBiotix said the deal was a "strategic step" to de-risk its supply chain and extend the market reach of SlimBiome, by adding manufacturing in North America.It said it would extend the commercial opportunity for its patented weight management product into the US weight management market, which was estimated to be worth $72bn in 2019.The company said partnering with an established player with an extensive reach to companies using high-value functional ingredients into their food applications would allow end users to reduce transport and tariff costs, while shortening lead-times and granting them access to Agropur's expert advice and capabilities to create value."We are pleased to announce the signing of a manufacturing and supply agreement with Agropur," said Dr Fred Narbel, the managing director of OptiBiotix's prebiotics division."We chose Agropur due to their world leading expertise in manufacturing and distributing specialty ingredients like SlimBiome® and their reputation for supplying high quality products to the food industry."We believe working with Agropur, and similar partners around the world, provides the best opportunity of increasing our global commercial reach and catering to the growing interest we are seeing in SlimBiome® from partners worldwide."Mike Homewood, vice-president of Agropur's Custom Solutions Group, added that the collaboration with OptiBiotix Health was "well-aligned" with his company's goal to bring innovation to its customers."The manufacturing and supply of SlimBiome is a natural fit within our model of solution-focused ingredients for the food, beverage and nutrition industries. We look forward to collaborating with OptiBiotix Health in the North American market."
More News
6 Sep 2016 07:53

OptiBiotix Says 100% Of Surveyed Customers Lost Weight Using GoFigure

Read more
25 Aug 2016 12:26

OptiBiotix Health reports wider first half loss

(ShareCast News) - OptiBiotix Health's shares dropped on Thursday as the medical product developer reported a wider first half loss. In the six months to the end of May, the loss before tax widened to £713,772 from £514,424 the same period a year earlier as administrative expenses grew to £802,0

Read more
9 Aug 2016 14:42

OptiBiotix Health snacks now available at UK Whole Foods

(ShareCast News) - AIM-listed OptiBiotix Health said its GoFigure meal replacement shakes and natural snack bars are now available at Whole Foods Market stores in the UK. The life sciences company, which develops compounds to tackle obesity, high cholesterol and diabetes, said GoFigure products will

Read more
2 Aug 2016 13:37

OptiBiotix appoints director of business development

(ShareCast News) - AIM-listed OptiBiotix Health has announced the appointment of Luis Gosalbez as director of business development with immediate effect. The company, which develops compounds to tackle obesity, high cholesterol, diabetes and skin care, said Gosalbez brings a strong scientific backgr

Read more
26 Jul 2016 12:16

OptiBiotix launches healthy food range, buys majority of partner

(ShareCast News) - Obesity, high cholesterol, diabetes and skin care focused life sciences company OptiBiotix Health announced on Tuesday the successful completion of a trial launch for its Slimbiome ingredients in a range of meal replacement shakes and natural snack bars. The AIM-traded firm also r

Read more
26 Jul 2016 10:15

OptiBiotix Buys Majority Of Healthy Weight Loss Co After Product Trial

Read more
14 Jul 2016 08:14

OptiBiotix Files Patent For Cholesterol-Reducing Supplement

Read more
19 May 2016 10:05

OptiBiotix Health Files New Patent For Microbial Protein Detection

Read more
14 Apr 2016 08:14

OptiBiotix Annual Loss Widens As It Progresses Development Programmes

Read more
7 Apr 2016 15:04

Earnings, Trading Statements Calendar - Week Ahead

Read more
7 Apr 2016 07:43

OptiBiotix Health Gets Good Results From Cholesterol Reduction Trials

Read more
5 Apr 2016 08:02

OptiBiotix Health Signs Development Agreement With Royal DSM

Read more
22 Mar 2016 10:27

OptiBiotix Signs Further Agreement With Spanish Research Council

Read more
17 Mar 2016 09:29

OptiBiotix Creates Skin Health Venture With Manchester University

Read more
5 Feb 2016 09:55

OptiBiotix raises £1m in new placing

(ShareCast News) - OptiBiotix had an additional £1m to play with on Friday, announcing a new placing of 1,282,051 ordinary shares at 78p each. The AIM-traded life sciences company, which specialises in products treating obesity, high cholesterol and diabetes, said the placing shares were issued to f

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.